COVID-19 Testing: For Businesses

As the nation’s leading respiratory hospital, we are committed to helping businesses keep their employees safe. Our Advanced Diagnostic Laboratories have developed COVID-19 tests that identify people who actively have COVID-19 or who have built antibodies to the SARS-CoV-2 virus.

Test Results in 7-10 Days

We know how important it is to identify if an employee has COVID-19 or has the antibodies. Test results are available within 7-10 days of order processing.

Tests Submitted to FDA through EUA

All three of our COVID-19 tests have applications pending with the Federal Drug Administration through its Emergency Use Authorization program.

Molecular RT-PCR Test (swab test) – confirms active cases of COVID-19

The molecular diagnostic test is the most widely used diagnostic test to determine active disease for COVID-19. A nasal swab is used to collect a sample. It detects genetic material from the SARS-CoV-2 virus. A positive molecular test indicates that a person has SARS-CoV-2 viral particles in the airways and has COVID-19 disease. A person with a positive molecular test should be considered infectious to other people and should self-isolate.

Antibody Tests (blood draw test) – helps to determine when it is safe to return to work

Antibody Test for IgM

IgM is the first antibody produced by the immune system. A positive IgM test indicates that a person has been infected and has begun to mount have an immune response to the virus. IgM antibodies disappear soon after the virus has been cleared from the body. A person with a positive IgM test may still have an active infection and should self-isolate.

Antibody Test for IgG

In most patients, IgG antibodies develop 7 to 10 days after symptoms of COVID-19 begin. The results of this test may indicate that a person has had COVID-19 in the recent past and has developed antibodies that may offer protection from future infection.

Antibodies can provide protection against re-infection, although strength of the protection and how long the protection may last varies by disease. People with antibodies may have a level of protection against SARS-CoV-2 re-infection, although researchers are still determining the level of protection.